Your browser doesn't support javascript.
loading
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
Sharma, Mukul; Hart, Robert G; Smith, Eric E; Bosch, Jacqueline; Eikelboom, John W; Connolly, Stuart J; Dyal, Leanne; Reeh, Kevin W; Casanova, Amparo; Diaz, Rafael; Lopez-Jaramillo, Patricio; Ertl, Georg; Störk, Stefan; Dagenais, Gilles R; Lonn, Eva M; Ryden, Lars; Tonkin, Andrew M; Varigos, John D; Bhatt, Deepak L; Branch, Kelley R H; Probstfield, Jeffrey L; Kim, Jae-Hyung; O'Donnell, Martin; Vinereanu, Dragos; A A Fox, Keith; Liang, Yan; Liu, Lisheng; Zhu, Jun; Pogosova, Nana; Maggioni, Aldo P; Avezum, Alvaro; Piegas, Leopoldo S; Keltai, Katalin; Keltai, Matyas; Berkowitz, Scott D; Yusuf, Salim.
Afiliação
  • Sharma M; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Hart RG; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Smith EE; Hotchkiss Brain Institute, University of Calgary, AB, Canada (E.E.S.).
  • Bosch J; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Eikelboom JW; School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada (J.B.).
  • Connolly SJ; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Dyal L; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Reeh KW; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Casanova A; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Diaz R; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Lopez-Jaramillo P; Estudios Clinicos Latino America and Instituto Cardiovascular de Rosario, Argentina (R.D.).
  • Ertl G; Research Institute, FOSCAL-Bucaramanga, Colombia (P.L.-J.).
  • Störk S; Comprehensive Heart Failure Center, University and University Hospital, Würzburg, Germany (G.E., S.S.).
  • Dagenais GR; Comprehensive Heart Failure Center, University and University Hospital, Würzburg, Germany (G.E., S.S.).
  • Lonn EM; Institut Universitaire de Cardiologie et Pneumologie de Quebec, Quebec City, Canada (G.R.D.).
  • Ryden L; Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada (M.S., R.G.H., J.B., J.W.E., S.J.C., L.D., K.W.R., A.C., E.M.L., S.Y.).
  • Tonkin AM; Karolinska Institutet, Stockholm, Sweden (L.R.).
  • Varigos JD; Monash University, Melbourne, Australia (A.M.T., J.D.V.).
  • Bhatt DL; Monash University, Melbourne, Australia (A.M.T., J.D.V.).
  • Branch KRH; Brigham and Women's Hospital Heart and Vascular Center, Harvard, Medical School, Boston, MA (D.L.B.).
  • Probstfield JL; University of Washington Medical Centre, Seattle (K.R.H.B.).
  • Kim JH; University of Washington, Seattle (K.R.H.B., J.L.P.).
  • O'Donnell M; University of Washington, Seattle (K.R.H.B., J.L.P.).
  • Vinereanu D; The Catholic University of Korea, Seoul, Korea (J.-H.K.).
  • A A Fox K; National University of Ireland Galway, Galway, Ireland (M.O.).
  • Liang Y; University of Medicine and Pharmacology Carol Davila University and Emergency Hospital, Bucharest, Romania (D.V.).
  • Liu L; Centre for Cardiovascular Science, University of Edinburgh, Scotland, United Kingdom (K.A.A.F.).
  • Zhu J; FuWai Hospital, Beijing, China (Y.L., L.L., J.Z.).
  • Pogosova N; FuWai Hospital, Beijing, China (Y.L., L.L., J.Z.).
  • Maggioni AP; FuWai Hospital, Beijing, China (Y.L., L.L., J.Z.).
  • Avezum A; National Research Centre for Preventative Medicine, Moscow, Russia (N.P.).
  • Piegas LS; ANMCO Research Center, Florence, Italy (A.P.M.).
  • Keltai K; Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil (A.A.).
  • Keltai M; University of Sao Paulo, Sao Paulo, Brazil (L.S.P.).
  • Berkowitz SD; Semmelweis University, Budapest, Hungary (K.K., M.K.).
  • Yusuf S; Semmelweis University, Budapest, Hungary (K.K., M.K.).
Stroke ; 51(10): 2901-2909, 2020 10.
Article em En | MEDLINE | ID: mdl-32951537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Inibidores da Agregação Plaquetária / Aspirina / Acidente Vascular Cerebral / Infarto Encefálico / Disfunção Cognitiva / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Inibidores da Agregação Plaquetária / Aspirina / Acidente Vascular Cerebral / Infarto Encefálico / Disfunção Cognitiva / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article